Habel D, Guermouche S, Guermouche M H
Insitut de Chimie, USTHB, Alger, Algeria.
Biomed Chromatogr. 1997 Jan-Feb;11(1):16-8. doi: 10.1002/(SICI)1099-0801(199701)11:1<16::AID-BMC619>3.0.CO;2-K.
A liquid chromatographic procedure for the direct determination of tinidazole in human serum is presented. It includes the use of a micellar mobile phase consisting of SDS (5.10(-2) M): propan-1-ol; (94:6, v/v) and a mu Bondapak CN column with UV detection at 320 nm. No solvent extraction or deproteinization are necessary. The linearity (0.1-10 mg L), the precision (3%), the reproducibility (1.3%), the recovery (99%), and the detection limit (0.1 mg L) in the tinidazole determination are comparable and sometimes greater than the corresponding tinidazole parameters when deproteinization and conventional reversed-phase HPLC are used. One hundred injections of serum samples do not affect the column life. The procedure is applied to ascertain the pharmacokinetics of 10 mg/kg of tinidazole.
本文介绍了一种直接测定人血清中替硝唑的液相色谱法。该方法使用由SDS(5×10⁻² M)、丙醇(94:6,v/v)组成的胶束流动相,并采用μ Bondapak CN柱,在320 nm处进行紫外检测。无需溶剂萃取或去蛋白处理。在替硝唑测定中,线性范围(0.1 - 10 mg/L)、精密度(3%)、重现性(1.3%)、回收率(99%)和检测限(0.1 mg/L)与使用去蛋白处理和传统反相高效液相色谱法时的相应替硝唑参数相当,有时甚至更高。对血清样品进行100次进样不会影响柱寿命。该方法用于确定10 mg/kg替硝唑的药代动力学。